Want to join the conversation?
$ROK 2Q15 10-Q: Sales were $1,550.8MM vs. $1,600.5MM in 2Q14. Cost of sales was $877.6MM vs. $944.7MM in 2Q14. Gross profit was $673.2MM vs. $655.8MM in 2Q14. Net income was $206MM vs. $180.3MM in 2Q14. Diluted earnings per share were $1.51 vs. $1.28 in 2Q14. Operating earnings was $334.2MM vs. $302.1MM in 2Q14.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)